🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Major props to Abhishek Solanki and Ron Chen for their phenomenal book "RT for GU Malignancies". The chapter on imaging for prostate cancer alone is well worth the purchase. 👍👏

Hey all! We need your help! My lab is creating radon exposure estimates and we need more information about basements in Utah homes. If you live in Utah and have 2 extra minutes, please complete this ?aire forms.gle/b31vo9xhGBrseG… #cleanairnow #utahcleanair University of Utah Health University of Utah

Great to chat with Kim Krisberg of the Nation's Health, the newspaper at the APHA, on health misinformation and effective ways to address and counter it. Remarkable quotes from Briony Swire-Thompson @Imi_Ahmed Brian C. Castrucci, DrPH and @NickSawyerMD thenationshealth.org/content/52/1/1… Huntsman Cancer Institute

Happy to share our predictive nomograms for patients with pathologically node positive prostate cancer #radonc #pcsm Jonathan Tward University of Utah Radiation Oncology Huntsman Cancer Institute clinical-genitourinary-cancer.com/article/S1558-…

I study alternative treatments, cancer misinformation and I also treat prostate cancer so hopefully, I can provide some insights. After some searching, there are some MAJOR red flags. Here is what I found: TLDR: Side-effect-free chemo should be renamed evidence-free chemo 🧵

Interested in #radonc Huntsman Cancer Institute University of Utah Health? Join our residents for meet & greets on 9/16 or 10/7 #match2023 Sign up here: docs.google.com/spreadsheets/d…

When looking at absolute benefit you can see how we likely need to move away from just STADT for intermediate risk and LTADT for high risk. Amazing data to personalize tx and ADT duration for pts. Jonathan Tward Nicholas Zaorsky, MD MS Himanshu Nagar Robert Dess Will Jackson @SouMyajiT_RO

#ProstateCancer risk stratification in NRG Oncology phase III randomized trials using multi-modal deep learning with digital histopathology. Presentation by Jonathan Tward Huntsman Cancer Institute. #ASTRO22 written coverage by @rksayyid University of Toronto on UroToday > bit.ly/3TZbBzn ASTRO

Have you listened to the latest QuadShot News podcast yet? Jonathan Tward describes where we are and where we are going in prostate cancer. Check it out here: quadshot-news-podcast.simplecast.com/episodes/11220… ASTRO Laura Dover Jonathan Tward Huntsman Cancer Institute ACRO - American College of Radiation Oncology #radonc

Twitterverse Poll: The ongoing healthcare financial crisis and workforce challenges will lead over 5 yrs…: Comment other ideas! I would appreciate if you reply and retweet to get a broad perspective. Sean McBride Matthew Katz, MD 🇺🇸🟦 Vinay Prasad MD MPH Eric Topol ASCO ASTRO

Genomic classifiers in personalized prostate cancer radiotherapy approaches - a systematic review and future perspe… pubmed.ncbi.nlm.nih.gov/36596346/

Initial results of a phase 2 pilot study of radium-223 and radiotherapy in untreated hormone-naïve men with oligometastatic #ProstateCancer to bone. Presentation by Jonathan Tward Huntsman Cancer Institute. ASCO #GU23 coverage by Christopher Wallis (he/him/his) > bit.ly/3lK8LBJ

Ability of STAR-CAP staging system to prognosticate risk of subsequent therapies after initial treatment of M0 #ProstateCancer. Presented by Jonathan Tward Huntsman Cancer Institute. ASCO #GU23 written coverage by Thenappan (Thenu) Chandrasekar, MD Jefferson Urology > bit.ly/3S6AI2M

Have a blast, and support men with prostate cancer! GU Cancer Research Program @HuntsmanCancer Huntsman Cancer Institute

Alas! My medical scribes always get into medical school and leave me 😉. If you know a smart college grad who would like to work as my scribe/research assistant for at least 1 year Huntsman Cancer Institute . Please encourage them to apply: tinyurl.com/y58yy9sj

Join us for the #HuntsmanSportsFest to help raise money for #prostatecancer research at HCI #ReasonToHope We can end cancer — together. Will you make a donation to help support our fundraising goal today? Weblink👉 rb.gy/819hr Huntsman Cancer Institute Bogdana Schmidt MD, MPH

#ASCO23 @asco PEACE-1 trial by Dr. Bossi👉Significant delay in disease progression and delay of serious GU obstructive events by radiation therapy in mCSPC (no OS benefit): results confirm the role of radiation in low volume denovo mCSPC OncoAlert UroToday.com Prostate Cancer Foundation

Tweetorial on our recently published paper in NEJM Evidence on the development and validation of the 1st predictive biomarker to guide ADT use in prostate cancer. Enjoy! #PCSM ArteraAI NRG Oncology Felix Feng Howard Sandler Edward Schaeffer, MD, PhD Jonathan Tward Andrew Armstrong

In our latest publication Jonathan Tward Skyler Johnson, MD and Bismarck Odei MD and I demonstrate the prognostic utility of the cell cycle progression score for patients with localized prostate cancer ascopubs.org/doi/pdf/10.120… #pcsm Huntsman Cancer Institute JCO Precision Oncology

X-torial: Cleaning up the misinformation about Joe Biden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA National Comprehensive Cancer Network (NCCN) PCa guidelines, hold leadership in NRG Oncology National Cancer Institute